IP Library Granted Patent US 6,861,070
Granted Patent B1
US 6,861,070 · App. 09/720,301 · Granted Mar 1, 2005

Medicinal compositions for treating evacuatory insufficiency

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,861,070
App. No.
09/720,301
Granted
Mar 1, 2005
Kind
B1
Abstract

A therapeutic agent for voiding dysfunction associated with neurogenic bladder where said agent contains tamsulosin or a pharmaceutically acceptable salt thereof.

Claims (3)

1. A method of treating voiding dysfunction associated with neurogenic bladder, comprising administering tamsulosin or a pharmaceutically acceptable salt to a patient with neurogenic bladder, wherein the patient does not exhibit lower urinary tract obstruction.

2. A method of treating neurogenic bladder comprising administering an effective amount of tamsulosin or a pharmaceutically acceptable salt thereof to a patient with neurogenic bladder.

3. A method of treating voiding dysfunction associated with neurogenic bladder, comprising administering and effective amount of tamsulosin or a pharmaceutically acceptable salt thereof to a patient with neurogenic bladder, wherein said voiding dysfunction is not associated with benign prostatic hypertrophy.

Assignments (1)
CHANGE OF NAME Recorded Nov 16, 2005
From: YAMANOUCHI PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 016784/0361 →